Hematologic Activity Alteration [PE] - N0000009065

Pharmacologic Class Information

Pharmacologic Code N0000009065
Pharmacologic Name Hematologic Activity Alteration
Pharmacologic Uses
  • blood viscosity reducer
Pharmacologic Concept Physiologic Effects - [PE]
Pharmacologic Concept Description This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

NDC Products with Hematologic Activity Alteration

The table contains 8 products whose active ingredient are classified under the same pharmacologic class Hematologic Activity Alteration [PE].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0615-8305Pentoxifylline Non-Proprietary Name: PentoxifyllineTablet, Extended ReleaseOralNcs Healthcare Of Ky, Llc Dba Vangard LabsACTIVE
0904-5448Pentoxifylline Non-Proprietary Name: PentoxifyllineTablet, Extended ReleaseOralMajor PharmaceuticalsACTIVE
60505-0033Pentoxifylline Non-Proprietary Name: PentoxifyllineTablet, Extended ReleaseOralApotex Corp.ACTIVE
63629-2910Pentoxifylline Non-Proprietary Name: PentoxifyllineTablet, Extended ReleaseOralBryant Ranch PrepackACTIVE
68682-101Pentoxifylline Non-Proprietary Name: PentoxifyllineTablet, Extended ReleaseOralOceanside PharmaceuticalsACTIVE
70518-1285Pentoxifylline Non-Proprietary Name: PentoxifyllineTablet, Extended ReleaseOralRemedyrepack Inc.ACTIVE
70954-668Pentoxifylline Non-Proprietary Name: PentoxifyllineTablet, Extended ReleaseOralAni Pharmaceuticals, Inc.ACTIVE
72162-2113Pentoxifylline Non-Proprietary Name: PentoxifyllineTablet, Extended ReleaseOralBryant Ranch PrepackACTIVE